Stay updated on Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.

Latest updates to the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page layout and styling were updated, while all core sections (e.g., eligibility, locations, outcomes) appear to be unchanged.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision from v3.4.1 to v3.4.2 was added, suggesting a small backend/UI tweak with no changes to the study information or how the page is used. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedThe revision label on the page was updated from v3.4.0 to v3.4.1. This appears to be a minor metadata update with no impact on content or functionality.SummaryDifference0.0%

- Check77 days agoChange DetectedUI text updates include adding a Show glossary option, standardizing capitalization for 'Last Update Submitted that Met QC Criteria' and the 'No FEAR Act Data' label, and updating the revision to v3.4.0. Core study content and essential details remain unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Crenezumab Long-Term Safety in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Crenezumab Long-Term Safety in Alzheimer's Clinical Trial page.